Amgen Inc (NASDAQ:AMGN) Q3 2022 Earnings Call dated Nov. 03, 2022. Corporate Participants: Arvind Sood -- Vice President of Investor Relations Bob Bradway -- Chairman &
Categories
Health Care
Ironwood Pharmaceuticals, Inc (IRWD) Q3 2022 Earnings Call Transcript
Ironwood Pharmaceuticals, Inc (NASDAQ:IRWD) Q3 2022 Earnings Call dated Nov. 03, 2022. Corporate Participants: Matt Roache -- Director of Investor Relations Thomas McCourt -- Chief Executive
Regeneron Pharmaceuticals Inc (REGN) Q3 2022 Earnings Call Transcript
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Q3 2022 Earnings Call dated Nov. 03, 2022. Corporate Participants: Ryan Crowe -- Vice President, Investor Relations Leonard Schleifer -- President and
Moderna Inc (MRNA) Q3 2022 Earnings Call Transcript
Moderna Inc (NASDAQ:MRNA) Q3 2022 Earnings Call dated Nov. 03, 2022. Corporate Participants: Lavina Talukdar -- Head of Investor Relations Stephane Bancel -- Chief Executive Officer
10X Genomics Inc (TXG) Q3 2022 Earnings Call Transcript
10X Genomics Inc (NASDAQ:TXG) Q3 2022 Earnings Call dated Nov. 02, 2022. Corporate Participants: Cassie Corneau -- Head of Investor Relations & Strategic Finance
CVS Health Corporation (CVS) Q3 2022 Earnings Call Transcript
CVS Health Corporation (NYSE:CVS) Q3 2022 Earnings Call dated Nov. 02, 2022. Corporate Participants: Larry McGrath -- Senior Vice President of Business Development and
Consider these factors before investing in Eli Lilly and Company (LLY)
The stock performance of Eli Lilly and Company (NYSE: LLY) has been exceptionally good this year, with the pharma giant defying the
Eli Lilly and Company (LLY) Q3 2022 Earnings Call Transcript
Eli Lilly and Company (NYSE:LLY) Q3 2022 Earnings Call dated Nov. 01, 2022. Corporate Participants: Joe Fletcher -- Senior Vice President, Investor Relations David
McKesson Corporation (MCK) Q2 2023 Earnings Call Transcript
McKesson Corporation (NYSE:MCK) Q2 2023 Earnings Call dated Nov. 01, 2022. Corporate Participants: Rachel Rodriguez -- Vice President of Investor Relations Brian S. Tyler -- Chief
CVS Health Corporation (CVS) Earnings: 3Q22 Key Numbers
CVS Health Corporation (NYSE: CVS) reported third quarter 2022 earnings results. Total revenues increased 10% year-over-year to $81.2 billion. Net loss attributable
Four noteworthy points from Pfizer’s (PFE) Q3 2022 earnings report
Shares of Pfizer Inc. (NYSE: PFE) were up 3% on Tuesday after the company beat estimates for the third quarter of 2022
Earnings: Highlights of Eli Lilly’s (LLY) Q3 2022 results
Eli Lilly and Company (NYSE: LLY) on Tuesday reported higher earnings and revenues for the third quarter of 2022. The company also
Pfizer (PFE) Q3 2022 Earnings: Key financials and quarterly highlights
Pfizer Inc. (NYSE: PFE) reported third quarter 2022 earnings results today. Revenues decreased 6% year-over-year to $22.6 billion. Reported net income increased
Vertex Pharmaceuticals Incorporated (VRTX) Q3 2022 Earnings Call Transcript
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q3 2022 earnings call dated Oct. 27, 2022 Corporate Participants: Susie Lisa -- Senior Vice President, Investor Relations Reshma
BioMarin Pharmaceutical Inc. (BMRN) Q3 2022 Earnings Call Transcript
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) Q3 2022 earnings call dated Oct. 26, 2022 Corporate Participants: Traci McCarty -- Vice President of Investor Relations Jean-Jacques
Merck & Co Inc (MRK) Q3 2022 Earnings Call Transcript
Merck & Co Inc (NYSE:MRK) Q3 2022 Earnings Call dated Oct. 27, 2022. Corporate Participants: Peter Dannenbaum -- Vice President of Investor Relations Robert
ABBV Infographic: AbbVie’s Q3 earnings beat estimates; revenue up 3%
Pharmaceutical company AbbVie, Inc. (NYSE: ABBV) reported a sharp increase in third-quarter adjusted earnings. The bottom line topped expectations, while revenues missed.
Infographic: Highlights of Merck’s (MRK) Q3 2022 earnings
Merck & Co., Inc. (NYSE: MRK) reported a modest increase in adjusted earnings for the third quarter of 2022 when the pharmaceutical
IQVIA Holdings Inc. (IQV) Q3 2022 Earnings Call Transcript
IQVIA Holdings Inc. (NYSE: IQV) Q3 2022 earnings call dated Oct. 26, 2022 Corporate Participants: Nick Childs -- Senior Vice President, Investor Relations and
Thermo Fisher Scientific Inc. (TMO) Q4 2022 Earnings Call Transcript
Thermo Fisher Scientific Inc. (NYSE: TMO) Q4 2022 earnings call dated Oct. 26, 2022 Corporate Participants: Rafael Tejada -- Vice President, Investor Relations Marc
Boston Scientific Corp. (BSX) Q3 2022 Earnings Call Transcript
Boston Scientific Corp. (NYSE: BSX) Q3 2022 earnings call dated Oct. 26, 2022 Corporate Participants: Lauren Tengler -- Vice President, Investor Relations Michael F.